Uso de cannabis como coadyuvante terapéutico en cancer y asma en felinos
The purpose of the review and exhaustive study of the literature in this document is to demonstrate the use of cannabis oil as an adjuvant in the treatment of the main diseases that affect felines, considering and categorizing some diseases there are two that have been Presenting very continuous at...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | bachelorThesis |
| Foilsithe / Cruthaithe: |
2021
|
| Ábhair: | |
| Rochtain ar líne: | http://dspace.utb.edu.ec/handle/49000/10304 |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Cuir clib leis | Achoimre: | The purpose of the review and exhaustive study of the literature in this document is to demonstrate the use of cannabis oil as an adjuvant in the treatment of the main diseases that affect felines, considering and categorizing some diseases there are two that have been Presenting very continuous at present and that treating them is being a clinical feat due to the complexity of these, such as asthma and cancer in felines. Cannabinoids as a natural alternative are taking a great force in general and veterinary medicine, as cannabis-derived products have become more available for medical and recreational use in humans, veterinarians are seeing more positive cases when risking for use of cannabidiol (CBD) in pets, commonly using (CBD) which is an oil extracted from the Cannabis seed. The great potential of medicinal cannabis, because it preserves bronchodilator and immunomodulatory properties, which are the main objectives of the treatment of feline asthma. To incorporate the use of phytocannabinoids into this therapy, a brief mention of some basic concepts is made. It is known that all vertebrates have an endocannabinoid system (SEC), consisting of receptors (CB1 and CB2), endogenous ligands (endocannabinoids: anandamide and 2AG) and degradation enzymes, the SEC is of great importance for the modulation function of the organism. Phytocannabinoids are derived from the plant, Cannabis sativa, the two most studied are CBD and THC, these interact with the CB1 and CB2 receptors (Jhon J. Betancurt 2020). Due to the little evidence and lack of literature on analysis and clinical trials on the therapeutic action of CBD in feline medicine, it has not been possible to establish a correct dosage, it is of vital importance that pharmaceutical sponsors begin with the development of a drug and research of the active substance to determine its therapeutic potential in the veterinary field. In the few clinical case studies carried out, they show the great potential of medicinal cannabis, because it retains bronchodilator and immunomodulatory properties, which are the main objectives of the treatment of feline asthma. To incorporate the use of phytocannabinoids into this therapy, a brief mention of some basic concepts is made. |
|---|